CHK2 was activated in OR CRC cells by examining the phosphorylation levels of CHK2 at both Thr68 and Ser516 in a panel of OR CRC cell lines and their oxaliplatin-sensitive counterparts (Fig. 1c). The gene discussed is CHEK2; the disease is colorectal carcinoma.